3 the designation of the s1-P10 and s2-P11 products. The s1-P10 and s2-P11 produced by WT NS5B in the first step were rapidly extended to generate the s1-P11 and s2-P12 in the presence of the incoming CTP, suggesting that the s1-P10 and s2-P11 were produced due to the initial template-product slippage. In order to increase the amount of product for better observation, the GTP concentration in assays of B and C was increased to 900 µM, and the GTP concentration in assay A and all other NTPs were supplied at 300 µM each. The gel thickness was 1.5 mm in panel B for better visualization of GTP and dinucleotides. In regular 0.75 mm gels, GTP was nondetectable and dinucleotides were barely detectable likely due to fast diffusion of their low molecular weights. The P2-free assays were carried out same as the P2-derived assays except that P2 was not included in the reaction. Figure S2 . The evidences of G:U mis and C:U mis events. A) The confirmatory assay flow chart for the G:U mis event. The boxed letters correspond to the misincorporated nucleotides. B) In the G:U mis confirmatory assay, the ATP and UTP were removed after the 9 mer product (P9)-containing EC was formed in the first step. ATP, UTP, or CTP was then supplied as the only NTP substrate at 300 µM to monitor further elongation events. The fraction of the 10-mer product (P10) intensity (int) (P10 int /(P9 int +P10 int )) values were calculated. The results indicated that P10 was hardly generated when only ATP was provided, gradually accumulated with time when only UTP was provided, and was very rapidly produced in the presence of the correct substrate CTP. These data suggest that the UMP misincorporation is the dominant misincorporation event in the G:U mis assay for generating the P10 m product when ATP and UTP were supplied as the only NTP substrates (Fig. 4 a and 
b). C)
The confirmatory assay flow chart for the C:U mis event. The boxed letters correspond to the misincorporated nucleotides. D) In the C:U mis confirmatory assay, the ATP, UTP, and CTP were removed after the 10 mer product (P10)-containing EC was formed in the first step. ATP, UTP, CTP, or GTP was then supplied as the only NTP substrate at 300 µM to monitor further elongation events. The data suggest that AMP, UMP, and CMP can be incorporated in the 10-mer to 11-mer misincorporation event, but the C:U mis was much faster than the C:A mis and C:C mis . Therefore the 13-mer product (P13 m ) is mainly derived from a C:U mis event followed by two regular UMP incorporation events when ATP, UTP, CTP were supplied as the only NTP substrates in the C:U mis assay (Fig. 4, c and d) . 
A-B)
Reaction flow chart (A) and data (B) for the NaCl and heparin inhibitory tests on P2-driven P9 formation. When the NaCl concentration was 100 mM or higher, or heparin concentration was 50 µg/mL or higher, the P9 product was not detected.
C-D)
The reaction flow chart (C), the PAGE analyses (D), and quantification (E) for heparin/NaCl challenge tests of the P9-containing complex stability. The P9-containing complexes formed by different NS5B constructs were incubated under either 100 µg/mL heparin or 100 µg/mL heparin combined with 500 mM NaCl for different time period (up to 7 days) before the fraction of the complex survived the incubation was estimated by the fractional intensity conversion from P9 to P10
see details in main text Materials and
Methods) plotted in panel E (only for the combined challenge). The majority of complexes formed by WT, AA, and N-91 constructs were able to complete the P9 to P10 conversion even after the 7-day challenge by 100 µg/mL heparin, while about 45% of the complexes survived the combined challenged after the 7 days. No significant differences were observed among the complexes by different NS5B constructs tested, suggesting that the complex stability were not affected by the perturbation (AA) or removal (N-91) of the NTD-RdRP intra-molecular interactions. 
